As the latest coronavirus variant upends expectations about the pandemic's coming months, drug manufacturers are working to expand treatment options to fight those stricken with severe disease. Even as new pills from Pfizer ...
Dec 14, 2021
0
2
(HealthDay)—People newly infected with COVID-19 might soon have access to what essentially is Tamiflu for the novel coronavirus, a breakthrough that experts say would drastically alter the course of the ongoing pandemic.
Oct 4, 2021
0
5
(HealthDay)—The U.S. Food and Drug Administration approved use of a higher dose of naloxone hydrochloride nasal spray for treating opioid overdose, the agency announced Friday.
May 4, 2021
0
2
When drug manufacturers raise the list price for brand-name prescription drugs, do patients' out-of-pocket costs rise too? A new study published in JAMA Network Open by Dr. Benjamin Rome and colleagues in the Brigham's Division ...
May 4, 2021
0
0
Human errors at a manufacturing plant forced Johnson & Johnson to throw out 15 million doses of its COVID-19 vaccine—enough to vaccinate 7% of the U.S. adult population.
Apr 2, 2021
0
3
Shortages of many essential drugs amid the COVID-19 crisis reveal serious vulnerabilities in the systems for supplying and distributing pharmaceuticals in the United States, according to a new report led by researchers at ...
Feb 5, 2021
0
1
When consumers get a prescription drug from the pharmacy, they assume that it's been tested and is safe to use. But what if a drug changes in harmful ways as it sits on the shelf or in the body?
Feb 5, 2021
0
9
Clinical trial data behind drug dose recommendations for elevated cholesterol and chronic obstructive pulmonary disease illustrate how larger doses may not be worth the extra costs for many types of patients, according to ...
May 6, 2020
0
3
On Monday, the U.S. Food and Drug Administration announced it was sending warning letters to 10 manufacturers to stop making products designed to allow youth to vape without getting caught by parents or teachers.
Apr 28, 2020
0
33
U.S. health regulators are telling drugmakers to immediately pull their popular heartburn drugs off the market after determining that a contamination issue with the medications poses a greater risk than previously thought.
Apr 1, 2020
0
129
